All Publications and Posters
-
ASCO Posters — June 12, 2023
Accuracy of genome-wide mutational analysis for tumor informed ctDNA guided MRD monitoring in bladder cancer
-
ASCO Posters — June 12, 2023
Ultrasensitive detection and monitoring of central nervous system tumors from plasma using personalized whole-genome ctDNA profiling
-
ASCO Meeting Library — June 2, 2023
Lab validation of an ultrasensitive ctDNA pan-cancer MRD assay using whole-genome sequencing
-
ASCO Meeting Library — May 31, 2023
Ultrasensitive detection and monitoring of central nervous system tumors from plasma using personalized whole-genome ctDNA profiling
-
ASCO Meeting Library — May 31, 2023
Accuracy of genome-wide mutational analysis for tumor-informed ctDNA-guided MRD monitoring in bladder cancer
-
AACR Posters — April 16, 2023
Whole genome cell-free tumor DNA mutational signatures from blood for early detection of recurrence of low stage lung adenocarcinoma
-
AACR Posters — April 16, 2023
Ultra-sensitive detection of circulating tumor DNA by WGS of blood samples from locally advanced rectal cancer patients receiving neoadjuvant therapy and enrolled in watch-and-wait strategies for organ preservation
-
AACR Posters — April 16, 2023
Detection of circulating tumor DNA by whole genome sequencing enables prediction of recurrence in stage III colorectal cancer patients with great inter-lab reproducibility
-
AACR Journals — June 15, 2022
Whole genome cell-free tumor DNA mutational signatures for noninvasive monitoring of pediatric brain cancers
-
AACR Journals — June 15, 2022
Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small cell lung cancer (NSCLC)
-
AACR Journals — June 15, 2022
Sensitive detection of circulating tumor DNA by whole genome sequencing: Validation of MRDetect using serial blood samples from stage III colorectal cancer patients
-
AACR Journals — June 15, 2022
Genome-wide circulating tumor DNA for monitoring treatment response and metastatic relapse in bladder cancer
-
Journal of Clinical Oncology — June 2, 2022
Lab validation of an ultrasensitive ctDNA pan-cancer MRD assay using whole-genome sequencing
-
Journal of Neuropathology & Experimental Neurology — June 1, 2022
Clinical utility of whole genome cell-free tumor DNA mutational signatures for liquid biopsy of pediatric brain tumors
-
AACR Posters — April 11, 2022
Sensitive detection of circulating tumor DNA by whole genome sequencing
-
AACR Posters — April 11, 2022
Whole genome cell-free tumor DNA mutational signatures for noninvasive monitoring of pediatric brain cancers
-
AACR Posters — April 11, 2022
Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small cell lung cancer (NSCLC)
-
AACR Posters — April 11, 2022
Genome-wide circulating tumor DNA for monitoring treatment response and metastatic relapse in bladder cancer
-
ASCO Meeting Library — June 4, 2021
Genome-wide circulating tumor DNA monitoring for bladder cancer treatment management and organ preservation
-
Nature — June 1, 2020
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
-
Cell Systems — January 22, 2020
Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization
-
AACR Journals — April 14, 2018
Genome-wide cell-free DNA mutation integration for sensitive cancer detection